InSilico Medicine’s $60 Million Series D Financing

Laura Testa
Tagged:

Davis Polk advised InSilico Medicine in the transaction.InSilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, closed its $60 million Series D financing from…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

…

This content is for Standard 1 Year members only.
Login Join Now